Different Risks of Thrombosis in Four Coagulation Defects Associated With Inherited Thrombophilia: A Study of 150 Families
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Deficiency of the naturally occurring anticoagulant proteins, such as antithrombin, protein C and protein S, and activated protein C resistance due to the factor V Leiden gene mutation is associated with inherited thrombophilia. So far, no direct comparison of the thrombotic risk associated with these genetic defects is available. In this study, we wish to compare the lifetime probability of developing thrombosis, the type of thrombotic symptoms, and the role of circumstantial triggering factors in 723 first- and second-degree relatives of 150 index patients with different thrombophilic defects. We found higher risks for thrombosis for subjects with antithrombin (risk ratio 8.1, 95% confidence interval [CI], 3.4 to 19.6), protein C (7.3, 95% CI, 2.9 to 18.4) or protein S deficiency (8.5, 95% CI, 3.5 to 20.8), and factor V Leiden (2.2, 95% CI, 1.1 to 4.7) than for individuals with normal coagulation. The risk of thrombosis for subjects with factor V Leiden was lower than that for those with all three other coagulation defects (0.3, 95% CI, 0.1 to 1.6), even when arterial and superficial vein thromboses were excluded and the analysis was restricted to deep vein thrombosis (0.3, 95% CI, 0.2 to 0.5). No association between coagulation defects and arterial thrombosis was found. The most frequent venous thrombotic manifestation was deep vein thrombosis with or without pulmonary embolism (90% in antithrombin, 88% in protein C, 100% in protein S deficiency, and 57% in factor V Leiden), but a relatively mild manifestation such as superficial vein thrombosis was common in factor V Leiden (43%). There was a predisposing factor at the time of venous thromboembolism in approximately 50% of cases for each of the four defects. In conclusion, factor V Leiden is associated with a relatively small risk of thrombosis, lower than that for antithrombin, protein C, or protein S deficiency. In addition, individuals with factor V Leiden develop less severe thrombotic manifestations, such as superficial vein thrombosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Koster, T., Vandenbroucke, J., Rosendaal, F., de Ronde, H., Briët, E., & Bertina, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,239
Resistance to Activated Protein C as a Basis for Venous Thrombosis
Svensson, P. J., & Dahlback, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300801 · Cited by 1,102
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Rosendaal, F., Koster, T., Vandenbroucke, J., & Reitsma, P. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 1,004
Inherited Thrombophilia: Part 1
Lane, D. A., Mannucci, P. M., Bauer, K. A., Bertina, R. M., Bochkov, N. P., Boulyjnkov, V., Chandy, M., Dahlback, B., Ginter, E. K., Miletich, J. P., et al. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650638 · Cited by 581
Self-citationKoeleman, B., Reitsma, P., Allaart, C., & Bertina, R. (1994) · Blood · doi:10.1182/blood.v84.4.1031.1031 · Cited by 445
Heijboer, H., Brandjes, D. P. M., Büller, H. R., Sturk, A., & ten Cate, J. W. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232202 · Cited by 445
Hereditary Protein S Deficiency: Clinical Manifestations
ENGESSER, L., BROEKMANS, A. W., BRIËT, E., BROMMER, E. J. P., & BERTINA, R. M. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-677 · Cited by 380
Koster, T., Rosendaal, F., Briet, E., van der Meer, F., Colly, L., Trienekens, P., Poort, Sr., Reitsma, P., & Vandenbroucke, J. (1995) · Blood · doi:10.1182/blood.v85.10.2756.bloodjournal85102756 · Cited by 364
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
Allaart, C. F., Poort, S. R., Reitsma, P. H., Bertina, R. M., Briët, E., Rosendaal, F. R., & Rosendaal, F. R. (1993) · The Lancet · doi:10.1016/0140-6736(93)90003-y · Cited by 351
Zoller, B., Berntsdotter, A., Garcia de Frutos, P., & Dahlback, B. (1995) · Blood · doi:10.1182/blood.v85.12.3518.bloodjournal85123518 · Cited by 306
Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
van Boven, H. H., Reitsma, P. H., Rosendaal, F. R., Bayston, T. A., Chowdhury, V, Borg, J.-Y., Bauer, K. A., Scharrer, I., Conard, J., & Lane, D. A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650289 · Cited by 230
Pabinger, I., & Schneider, B. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.6.742 · Cited by 224
Characterization of the Molecular Defect in Factor VR506A
Kalafatis, M., Bertina, R. M., Rand, M. D., & Mann, K. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.4053 · Cited by 216
The clinical spectrum of heterozygous protein C deficiency in a large New England kindred
Bovill, E., Bauer, K., Dickerman, J., Callas, P., & West, B. (1989) · Blood · doi:10.1182/blood.v73.3.712.712 · Cited by 202
Frezzato, M., Tosetto, A., & Rodeghiero, F. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008713 · Cited by 151
Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V
Heeb, M., Kojima, Y., Greengard, J. S., & Griffin, J. H. (1995) · Blood · doi:10.1182/blood.v85.12.3405.bloodjournal85123405 · Cited by 120
Hille, E. T. M., Westendorp, R. G. J., Vandenbroucke, J. P., & Rosendaal, F. R. (1997) · Blood · doi:10.1182/blood.v89.6.1963 · Cited by 89
Lensen, R., Rosendaal, F. R., Koster, T., Allaart, C. F., de Ronde, H., Vandenbroucke, J. P., Reitsma, P. H., & Bertina, R. M. (1996) · Blood · doi:10.1182/blood.v88.11.4205.4205 · Cited by 82
Cited by
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972
Genetic Susceptibility to Venous Thrombosis
Seligsohn, U., & Lubetsky, A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441607 · Cited by 822
Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 616
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Lane, D. A., & Grant, P. J. (2000) · Blood · doi:10.1182/blood.v95.5.1517.005k48_1517_1532 · Cited by 495
Inherited antithrombin deficiency: a review
PATNAIK, M. M., & MOLL, S. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2008.01830.x · Cited by 401
Metadata
- Authors
- Martinelli, I., Mannucci, P. M., De Stefano, V., Taioli, E., Rossi, V., Crosti, F., Paciaroni, K., Leone, G., & Faioni, E. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-10-01
- Volume
- 92
- Issue
- 7
- Pages
- 2353-2358
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2272401759
- Cited by
- 444
- References
- 21
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.